Sino-German High-Tech Fund

The Sino-German High-Tech Fund operates as a venture capital investment firm and private equity growth expansion fund, primarily targeting promising German high-tech companies. It focuses strategically on sectors including high-end manufacturing, energy, and life sciences, specifically gene technology and healthcare, along with nutrition. The fund aims to channel significant capital into these areas, demonstrating a clear mandate to foster innovation and technological advancement.

Established in 2016, the fund is based in Wan Chai, China, reflecting its inherent cross-border nature and the strategic intent behind its formation. Its inception aligns with broader efforts to bridge technological expertise and investment between Germany and China, facilitating growth for ventures poised for international expansion and market leadership in critical industries.

The fund's investment strategy focuses on German enterprises, providing capital to expand product development and strengthen capabilities in specialized fields. Its long-term vision is to serve as a catalyst for growth, enabling its portfolio companies to scale their technologies and achieve greater market penetration, ultimately contributing to the advancement of Sino-German industrial and technological cooperation.